HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): David E. Lammermeier Michael S. Sweeney Hans E. Haupt Branislav Radovancevic Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lammermeier, D. E. Articles by Frazier, O. H. Search for Related Content PubMed PubMed Citation Articles by Lammermeier, D. E. Articles by Frazier, O. H.

Ann Thorac Surg 1990;50:222-225
© 1990 The Society of Thoracic Surgeons

---

Articles

Use of potentially infected donor hearts for cardiac transplantation

Divisions of Cardiovascular Surgery, Texas Heart Institute and The University of Texas Health Science Center at Houston, Houston, Texas USA

^_* Address reprint requests to Dr Sweeney, University of Texas Medical School, 6431 Fannin, MSB 1.220, Houston, TX 77030.

Despite the nationwide shortage of heart donors, more patients, some of whom are critically ill, are being accepted as candidates for transplantation. Thus, on occasion, we have liberalized our donor criteria to meet the demand. We have recently transplanted 16 potentially infected donor hearts into critically ill recipients. Of these 16 donors, 7 had multiple positive blood cultures as follows: Streptococcus pneumoniae (3), Staphylococcus aureus (2), Klebsiella pneumoniae (1), and Enterobacter sp (1). Seven other donors were accepted despite high fevers (rectal temperature >38.9 °C), leukocytosis (>18 x 10⁹/L [>18,000 cells/µL]), and pulmonary infiltrates with positive sputa (Enterobacter [3], Klebsiella pneumoniae [2], and Staphylococcus [2]). Two other donors with hepatitis B surface antigen positivity were deemed at high risk but were used because the recipients were in immediate need. Early mortality (30 days) among the recipients was [equation] (18.7%) with 1 patient dying of uncontrolled allograft rejection, 1 of hepatic failure, and 1 of Pseudomonas septicemia. Late mortality (>30 days after operation) occurred in 6 patients: 2 patients died of hepatic failure, 3 died of graft atherosclerosis, and 1 died of iatrogenic hemorrhage after a liver biopsy. Only 1 patient died of infection unrelated to that of the donor, and the other patients had no infectious complications resulting from the organisms identified in their respective donors. Use of potentially infected donor hearts resulted in surprisingly few infectious complications in this group of recipients. This practice can be safe and should be considered when other options are unavailable.

This article has been cited by other articles:

				A. Schaffner Pretransplant Evaluation for Infections in Donors and Recipients of Solid Organs Clinical Infectious Diseases, July 1, 2001; 33(Supplement_1): S9 - S14. [Abstract] [Full Text] [PDF]

				R. Soave Prophylaxis Strategies for Solid-Organ Transplantation Clinical Infectious Diseases, July 1, 2001; 33(Supplement_1): S26 - S31. [Abstract] [Full Text] [PDF]

				R. W. Emery, F. Eales, L. D. Joyce, T. J. Von Rueden, R. M. King, C. R. Jorgensen, M. R. Pritzker, K. E. Johnson, K. D. Lake, and K. V. Arom Mechanical circulatory assistance after heart transplantation Ann. Thorac. Surg., January 1, 1991; 51(1): 43 - 47. [Abstract] [PDF]